Please Wait

Applying Filters...

FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Cefazolin Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 16 USDMF, 9 CEP/COS, 8 JDMF, 1 EU WC, 8 KDMF, 3 NDC API, 14 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

136 FDF Dossiers, 94 FDA Orange Book, 15 Europe, 16 Canada, 11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 1GM BASE/50ML (EQ 20MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 2GM BASE/100ML (EQ 20MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 3GM BASE/150ML (EQ 20MG BASE/ML), INJECTABLE;INJECTION - EQ 1GM BASE/VIAL, INJECTABLE;INJECTION - EQ 2GM BASE/VIAL, INJECTABLE;INJECTION - EQ 3GM BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 Kirsch Pharma, 2 Actylis, 4 Roquette

EXCIPIENTS BY APPLICATIONS

7 Parenteral, 2 Fillers, Diluents & Binders, 1 API Stability Enhancers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 7 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 2 Regulatory FDF Prices

MARKET PLACE

16 APIs, 2 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM

2 EDQM

$ Xls

Filters

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL

SOLUTION;INTRAVENOUS - EQ 1GM BASE/50ML (EQ 20MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 2GM BASE/100ML (EQ 20MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 3GM BASE/150ML (EQ 20MG BASE/ML)

X

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Cefazolin Sodium

Cefazolin Sodium

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers

16 USDMF

9 CEP/COS

8 JDMF

1 EU WC

8 KDMF

3 NDC API

14 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

136 FDF Dossiers

94 FDA Orange Book

15 Europe

16 Canada

11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 1GM BASE/50ML (EQ 20MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 2GM BASE/100ML (EQ 20MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 3GM BASE/150ML (EQ 20MG BASE/ML)

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

3 Kirsch Pharma

2 Actylis

4 Roquette

EXCIPIENTS BY APPLICATIONS

7 Parenteral

2 Fillers, Diluents & Binders

1 API Stability Enhancers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow

7 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions

2 Regulatory FDF Prices

MARKET PLACE

16 APIs

2 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM

Filters